Page last updated: 2024-09-05

rs 127445 and sb 206553

rs 127445 has been researched along with sb 206553 in 2 studies

Compound Research Comparison

Studies
(rs 127445)
Trials
(rs 127445)
Recent Studies (post-2010)
(rs 127445)
Studies
(sb 206553)
Trials
(sb 206553)
Recent Studies (post-2010) (sb 206553)
29118102028

Protein Interaction Comparison

ProteinTaxonomyrs 127445 (IC50)sb 206553 (IC50)
Cytochrome P450 1A2Homo sapiens (human)0.05
5-hydroxytryptamine receptor 2CHomo sapiens (human)0.0094

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D1
Abdel-Raziq, MS; Gabr, MT1

Other Studies

2 other study(ies) available for rs 127445 and sb 206553

ArticleYear
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:2

    Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists

2004
Pharmacophore-based tailoring of biphenyl amide derivatives as selective 5-hydroxytryptamine 2B receptor antagonists.
    MedChemComm, 2018, Jun-01, Volume: 9, Issue:6

    Topics:

2018